Xiao-Bin Zheng

† First or co-first author, * Corresponding or co-corresponding author, bold names are lab members

Journal Article 2025 iScience

A plasma metabolite-based test to detect minimal residual disease in post-surgery patients with colorectal cancer

Zhengran Zhou^†, Richard Mortensen^†, Peishan Hu^†, Bo Jin, Xiao-Bin Zheng, Xiao Li, James Schilling, C. James Chou, Karl G. Sylvester, Yanghai Cong, Xiaojian Wu, Feng GAO^*, Xuefeng B. Ling^*, Xuanhui Liu^*

Conference Paper 2021 Journal of Clinical Oncology

Multi-omics longitudinal analyses in stages I to III CRC patients: Surveillance liquid biopsy test to predict early recurrence and enable risk-stratified postoperative CRC management.

Xuanhui Liu^†, Yani Zhang, Xiurui Zhu, Sheeno P. Thyparambil, Wei-Li Liao, Xiao-Bin Zheng, Jin You, Ashiq Masood, Zhen Li, Gabriel Yang, Xiaoming Yao, Shiying Hao, Robert Heaton, James Schilling, Karl G. Sylvester, Jiayu Liao, Feng GAO, Ping Lan, Xuefeng Ling, Xiaojian Wu^*

Journal Article 2020 European Journal of Surgical Oncology

Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients

Jia Ke^†, Xuan-Hui Liu^†, Xiao-Feng Jiang, Zhen He, Jian Xiao, Bin Zheng, Yu-Feng Chen, Ze-Rong Cai, Xiao-Bin Zheng, Yi-Feng Zou, Ping Lan, Xiao-Jian Wu^*, Feng GAO^*

PMID DOI

All related publications

A plasma metabolite-based test to detect minimal residual disease in post-surgery patients with colorectal cancer

Multi-omics longitudinal analyses in stages I to III CRC patients: Surveillance liquid biopsy test to predict early recurrence and enable risk-stratified postoperative CRC management.

Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients